3.3206
price down icon0.01%   -0.0006
 
loading
Precigen Inc stock is traded at $3.3206, with a volume of 1.09M. It is down -0.01% in the last 24 hours and down -24.21% over the past month. Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
See More
Previous Close:
$3.32
Open:
$3.26
24h Volume:
1.09M
Relative Volume:
0.24
Market Cap:
$1.17B
Revenue:
$6.31M
Net Income/Loss:
$-246.87M
P/E Ratio:
-2.3705
EPS:
-1.4008
Net Cash Flow:
$-75.62M
1W Performance:
-5.42%
1M Performance:
-24.21%
6M Performance:
-11.47%
1Y Performance:
+84.43%
1-Day Range:
Value
$3.24
$3.38
1-Week Range:
Value
$3.11
$3.64
52-Week Range:
Value
$1.11
$5.465

Precigen Inc Stock (PGEN) Company Profile

Name
Name
Precigen Inc
Name
Phone
301-556-9900
Name
Address
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
Name
Employee
25
Name
Twitter
@precigen
Name
Next Earnings Date
2026-03-25
Name
Latest SEC Filings
Name
PGEN's Discussions on Twitter

Compare PGEN vs VRTX, REGN, ALNY, ARGX, ONC

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
PGEN icon
PGEN
Precigen Inc
3.32 1.17B 6.31M -246.87M -75.62M -1.4008
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
457.83 116.36B 12.07B 3.95B 3.19B 15.33
REGN icon
REGN
Regeneron Pharmaceuticals Inc
736.25 77.96B 14.34B 4.50B 3.77B 41.56
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
318.35 41.26B 3.71B 313.75M 465.38M 2.2571
ARGX icon
ARGX
Argen X Se Adr
677.78 42.36B 4.16B 1.29B 734.26M 19.59
ONC icon
ONC
Beone Medicines Ltd Adr
281.06 31.38B 5.36B 287.73M 924.18M 2.5229

Precigen Inc Stock (PGEN) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-15-25 Upgrade JP Morgan Underweight → Neutral
Mar-22-24 Downgrade JP Morgan Neutral → Underweight
May-23-23 Initiated JP Morgan Neutral
Nov-18-22 Initiated Cantor Fitzgerald Overweight
Feb-25-21 Initiated Stifel Buy
Feb-22-21 Initiated Wells Fargo Overweight
Feb-18-21 Initiated B. Riley Securities Buy
May-08-20 Initiated H.C. Wainwright Buy
View All

Precigen Inc Stock (PGEN) Latest News

pulisher
Mar 19, 2026

Precigen, Inc. Hits Day Low of $3.27 Amid Price Pressure - Markets Mojo

Mar 19, 2026
pulisher
Mar 19, 2026

Precigen Stock Hits Day Low of $3.94 Amid Price Pressure - Markets Mojo

Mar 19, 2026
pulisher
Mar 16, 2026

Precigen (PGEN) insider exercises 143,678 RSUs into common stock - Stock Titan

Mar 16, 2026
pulisher
Mar 16, 2026

Director Frank Steven converts 71,839 RSUs into Precigen (PGEN) common stock - Stock Titan

Mar 16, 2026
pulisher
Mar 16, 2026

Precigen (PGEN) director converts 71,839 RSUs into common stock, now holding 305,776 shares - Stock Titan

Mar 16, 2026
pulisher
Mar 16, 2026

Director at Precigen (PGEN) converts 71,839 vested RSUs into shares - Stock Titan

Mar 16, 2026
pulisher
Mar 16, 2026

[Form 4] PRECIGEN, INC. Insider Trading Activity - Stock Titan

Mar 16, 2026
pulisher
Mar 16, 2026

Precigen (PGEN) director exercises RSUs, adds 71,839 common shares - Stock Titan

Mar 16, 2026
pulisher
Mar 16, 2026

RSU vesting gives Precigen (PGEN) director 71839 new common shares - Stock Titan

Mar 16, 2026
pulisher
Mar 16, 2026

RSU vesting adds 71,839 shares to Precigen (PGEN) director’s holdings - Stock Titan

Mar 16, 2026
pulisher
Mar 16, 2026

Precigen, Inc. Hits Day High with Strong 7.01% Intraday Surge - Markets Mojo

Mar 16, 2026
pulisher
Mar 15, 2026

Boxer Capital Management LLC Makes New $2.80 Million Investment in Precigen, Inc. $PGEN - MarketBeat

Mar 15, 2026
pulisher
Mar 14, 2026

Cantor Fitzgerald Reaffirms Overweight Rating on Precigen (PGEN) - MSN

Mar 14, 2026
pulisher
Mar 13, 2026

Precigen (NASDAQ:PGEN) Stock Price Up 7.5%Should You Buy? - MarketBeat

Mar 13, 2026
pulisher
Mar 13, 2026

Precigen to Announce Full Year 2025 Financial Results and Provide Business Updates on March 25 - The Malaysian Reserve

Mar 13, 2026
pulisher
Mar 13, 2026

Is Precigen (PGEN) Reflecting Its Recent Surge Despite Steep Short Term Pullback - simplywall.st

Mar 13, 2026
pulisher
Mar 12, 2026

Assessing Precigen (PGEN) Valuation After Recent Share Price Weakness And Conflicting Fair Value Estimates - Yahoo Finance

Mar 12, 2026
pulisher
Mar 12, 2026

Randal Kirk (PGEN) reports new Precigen equity awards and large indirect stake - Stock Titan

Mar 12, 2026
pulisher
Mar 12, 2026

PRECIGEN (PGEN) director granted RSUs, stock options and shares as compensation - Stock Titan

Mar 12, 2026
pulisher
Mar 12, 2026

Precigen (PGEN) director granted RSUs, options and shares as board pay - Stock Titan

Mar 12, 2026
pulisher
Mar 12, 2026

Director at Precigen (NASDAQ: PGEN) granted stock, RSUs and options - Stock Titan

Mar 12, 2026
pulisher
Mar 12, 2026

PRECIGEN (PGEN) director Vinita Gupta receives RSUs, stock options and shares - Stock Titan

Mar 12, 2026
pulisher
Mar 12, 2026

Director at Precigen (NASDAQ: PGEN) receives stock, RSUs and options - Stock Titan

Mar 12, 2026
pulisher
Mar 12, 2026

Precigen (PGEN) director awarded stock, RSUs and options as board fees - Stock Titan

Mar 12, 2026
pulisher
Mar 12, 2026

Precigen (PGEN) director granted RSUs, stock options and shares as retainer - Stock Titan

Mar 12, 2026
pulisher
Mar 12, 2026

Precigen (NASDAQ:PGEN) Upgraded at Zacks Research - MarketBeat

Mar 12, 2026
pulisher
Mar 11, 2026

Precigen to Announce Full Year 2025 Financial Results - National Today

Mar 11, 2026
pulisher
Mar 11, 2026

Biotech firm Precigen schedules March 25 call on 2025 results - Stock Titan

Mar 11, 2026
pulisher
Mar 11, 2026

Precigen (PGEN) to Release Quarterly Earnings on Wednesday - MarketBeat

Mar 11, 2026
pulisher
Mar 07, 2026

Precigen, Inc. (NASDAQ:PGEN) Given Average Rating of "Hold" by Brokerages - MarketBeat

Mar 07, 2026
pulisher
Mar 07, 2026

Gainers Report: Is Precigen Inc forming a bullish divergence2025 Geopolitical Influence & Weekly Setup with High ROI Potential - baoquankhu1.vn

Mar 07, 2026
pulisher
Mar 06, 2026

Precigen earnings in focus as gene therapy revenue ramps up By Investing.com - Investing.com Canada

Mar 06, 2026
pulisher
Mar 06, 2026

Precigen earnings in focus as gene therapy revenue ramps up - Investing.com

Mar 06, 2026
pulisher
Mar 05, 2026

Precigen (PGEN) Surged Following the Early Approval of Papziemos - Insider Monkey

Mar 05, 2026
pulisher
Mar 03, 2026

EV Market: Is Precigen Inc stock influenced by commodity prices2025 Investor Takeaways & Technical Pattern Alert System - baoquankhu1.vn

Mar 03, 2026
pulisher
Mar 02, 2026

PGEN Stock Price, Quote & Chart | PRECIGEN INC (NASDAQ:PGEN) - ChartMill

Mar 02, 2026
pulisher
Feb 27, 2026

Precigen, Inc. (PGEN) Stock Analysis: Unveiling A 123% Upside Potential In Biotech - DirectorsTalk Interviews

Feb 27, 2026
pulisher
Feb 27, 2026

Lansing Street Advisors Takes $1.80 Million Position in Precigen, Inc. $PGEN - MarketBeat

Feb 27, 2026
pulisher
Feb 27, 2026

Precigen (NASDAQ:PGEN) Share Price Passes Below Two Hundred Day Moving AverageWhat's Next? - MarketBeat

Feb 27, 2026
pulisher
Feb 25, 2026

Aug Update: Can Precigen Inc beat the S P 5002025 Winners & Losers & Safe Capital Growth Tips - baoquankhu1.vn

Feb 25, 2026
pulisher
Feb 24, 2026

Precigen, Inc. Hits Day Low of $4.04 Amid Price Pressure - Markets Mojo

Feb 24, 2026
pulisher
Feb 24, 2026

Precigen, Inc. Experiences Evaluation Revision Amidst Mixed Market Performance Indicators - Markets Mojo

Feb 24, 2026
pulisher
Feb 21, 2026

Precigen, Inc. (PGEN): Investor Outlook On A Biotech With 88% Potential Upside - DirectorsTalk Interviews

Feb 21, 2026
pulisher
Feb 20, 2026

Why analysts remain bullish on Precigen Inc. stockMarket Growth Report & Advanced Technical Analysis Signals - mfd.ru

Feb 20, 2026
pulisher
Feb 19, 2026

Key Takeaways - StocksToTrade

Feb 19, 2026
pulisher
Feb 19, 2026

Precigen (NASDAQ:PGEN) Shares Down 6%What's Next? - MarketBeat

Feb 19, 2026
pulisher
Feb 18, 2026

Strategic Moves Boost PGEN Momentum Amidst Market Shifts - StocksToTrade

Feb 18, 2026
pulisher
Feb 18, 2026

Precigen (NASDAQ:PGEN) Hits New 12-Month HighHere's What Happened - MarketBeat

Feb 18, 2026
pulisher
Feb 18, 2026

Can Precigen Translate PAPZIMEOS Momentum Into Revenue Growth And Shareholder Gains? - RTTNews

Feb 18, 2026
pulisher
Feb 17, 2026

Precigen (NASDAQ:PGEN) Trading 5.2% HigherStill a Buy? - MarketBeat

Feb 17, 2026
pulisher
Feb 17, 2026

Precigen stock hits 52-week high at 5.23 USD - Investing.com

Feb 17, 2026

Precigen Inc Stock (PGEN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Precigen Inc Stock (PGEN) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
KIRK RANDAL J
Director
Dec 22 '25
Sale
4.18
1,900,036
7,942,150
341,189
$45.24
price down icon 0.69%
$27.54
price down icon 0.83%
$51.97
price down icon 0.84%
$88.23
price down icon 1.29%
$140.46
price down icon 2.50%
ONC ONC
$281.25
price down icon 0.51%
Cap:     |  Volume (24h):